The molecular mechanisms of susceptibility to malignant hyperthermia are complex. The malignant hyperthermia susceptibility phenotype should be reserved for patients who have a personal or family history consistent with malignant hyperthermia under anaesthesia and are subsequently demonstrated through diagnostic testing to be at risk. Copyright © 2023 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.
Philip M Hopkins. What is malignant hyperthermia susceptibility? British journal of anaesthesia. 2023 Jul;131(1):5-8
PMID: 37198032
View Full Text